July 29, 2024 – Dr. Zahra Kashi, Founder, Chief Scientific Officer, and Lab Director at Kashi Clinical Laboratories, and Dr. Nathan Fuller, CEO and Founder of Gene2Med, LLC, share their insights, experiences and best practices to provide viewers with:
- An introduction to Pharmacogenomics (PGx)
- Clinical application
- Current challenges regarding personalized medicine
- How to interpret and use the PGx results in practice
Watch the video and learn more about our Comprehensive PGx testing.
About Kashi Clinical Laboratories
Kashi Clinical Laboratories (KCL) is a fully accredited clinical laboratory providing specialized solutions to academic institutions, biopharma, hospitals, long-term care facilities, and transplant centers around the world. Founded in 2006, KCL provides a full range of pre and post-transplant testing services, clinical pathology and genomics, virology, genetic testing, toxicology, and clinical trial support. KCL is renowned for its rapid turnaround time, scientific expertise, customer service, and innovation using state-of-the-art technology.
